Build on our experience of more than 245 rare disease studies in 96 countries to fulfill your promise of hope to millions around the world.
Rare diseases are often life-threatening or chronically debilitating diseases which, when grouped together, are more common than initially thought. The situation is critical, and the answers lie in medical research. At IQVIA, we are committed to making medical research more effective and we recognize that working in collaboration, with networks like the European reference networks and G2M are crucial to success.
We invite you to register now and join this live webinar.
In this webinar we will share insights into how to work more collegially with academics, industry and patient groups to ultimately improve the care and treatment of patients with rare diseases.
This webinar will be hosted by Pharmaphorum and IQVIA.
Join the experts:
- Dr Jeff Keefer, VP & head of the Pediatric and Rare Disease Centres of Excellence, IQVIA
- Dr Jean-Meidi Alili, Senior pharmacist, Necker university hospital, AP-HP Paris, French healthcare network for rare metabolic diseases (G2M) and member of Metabolic Hereditary Diseases European reference Network (MetabERN)
- Dr Joanne Hackett, head of Genomic and Precision medicine, IQVIA
Gain new insights into:
- Improving the care and treatment of patients with rare diseases
- Developments in genomics medicine to improve diagnosis of rare diseases
Following the presentation, our team of experts will host a Q&A session. We highly encourage your participation.
We look forward to sharing our insights with you.
Related solutions
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
